{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:46:18Z","timestamp":1791002778722,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1038\/s41401-023-01112-8","type":"journal-article","created":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T12:01:47Z","timestamp":1686744107000},"page":"2296-2306","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Chloroquine enhances the efficacy of chemotherapy drugs against acute myeloid leukemia by inactivating the autophagy pathway"],"prefix":"10.1038","volume":"44","author":[{"given":"Han-lin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-juan","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gao-ya","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-hao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-biao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-feng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-tong","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-bo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,14]]},"reference":[{"key":"1112_CR1","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra1406184","volume":"373","author":"H D\u00f6hner","year":"2015","unstructured":"D\u00f6hner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med. 2015;373:1136\u201352.","journal-title":"N Engl J Med"},{"key":"1112_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3324\/haematol.2008.001263","volume":"94","author":"EH Estey","year":"2009","unstructured":"Estey EH. Treatment of acute myeloid leukemia. Haematologica. 2009;94:10\u201316.","journal-title":"Haematologica"},{"key":"1112_CR3","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H D\u00f6hner","year":"2017","unstructured":"D\u00f6hner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, B\u00fcchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129:424\u201347.","journal-title":"Blood"},{"key":"1112_CR4","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3390\/cancers10110429","volume":"10","author":"M Luppi","year":"2018","unstructured":"Luppi M, Fabbiano F, Visani G, Martinelli G, Venditti A. Novel agents for acute myeloid leukemia. Cancers (Basel). 2018;10:429.","journal-title":"Cancers (Basel)"},{"key":"1112_CR5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/tpj.2014.80","volume":"15","author":"J Meg\u00edas-Vericat","year":"2015","unstructured":"Meg\u00edas-Vericat J, Rojas L, Herrero M, Bos\u00f3 V, Montesinos P, Moscard\u00f3 F, et al. Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: a systematic review and meta-analysis of observational studies. Pharmacogenomics J. 2015;15:109\u201318.","journal-title":"Pharmacogenomics J"},{"key":"1112_CR6","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.2147\/OTT.S191621","volume":"12","author":"J Zhang","year":"2019","unstructured":"Zhang J, Gu Y, Chen B. Mechanisms of drug resistance in acute myeloid leukemia. OncoTargets Ther. 2019;12:1937\u201345.","journal-title":"OncoTargets Ther"},{"key":"1112_CR7","first-page":"e33165","volume":"14","author":"EY Arwanih","year":"2022","unstructured":"Arwanih EY, Louisa M, Rinaldi I, Wanandi SI. Resistance mechanism of acute myeloid leukemia cells against daunorubicin and cytarabine: a literature review. Cureus. 2022;14:e33165.","journal-title":"Cureus"},{"key":"1112_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0098-2997(94)00040-A","volume":"16","author":"C Shustik","year":"1995","unstructured":"Shustik C, Dalton W, Gros P. P-glycoprotein-mediated multidrug resistance in tumor cells: biochemistry, clinical relevance and modulation. Mol Asp Med. 1995;16:1\u201378.","journal-title":"Mol Asp Med"},{"key":"1112_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fphar.2013.00089","volume":"4","author":"RN Ganapathi","year":"2013","unstructured":"Ganapathi RN, Ganapathi MK. Mechanisms regulating resistance to inhibitors of topoisomerase II. Front Pharmacol. 2013;4:89\u201389.","journal-title":"Front Pharmacol"},{"key":"1112_CR10","doi-asserted-by":"publisher","first-page":"8991","DOI":"10.3390\/ijms21238991","volume":"21","author":"J Xu","year":"2020","unstructured":"Xu J, Patel NH, Gewirtz DA. Triangular relationship between p53, autophagy, and chemotherapy resistance. Int J Mol Sci. 2020;21:8991.","journal-title":"Int J Mol Sci"},{"key":"1112_CR11","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1158\/0008-5472.CAN-07-5528","volume":"68","author":"J Cai","year":"2008","unstructured":"Cai J, Damaraju VL, Groulx N, Mowles D, Peng Y, Robins MJ, et al. Two distinct molecular mechanisms underlying cytarabine resistance in human leukemic cells. Cancer Res. 2008;68:2349\u201357.","journal-title":"Cancer Res"},{"key":"1112_CR12","first-page":"1373","volume":"99","author":"MJ Veuger","year":"2002","unstructured":"Veuger MJ, Heemskerk MH, Honders MW, Willemze R, Barge RM. Functional role of alternatively spliced deoxycytidine kinase in sensitivity to cytarabine of acute myeloid leukemic cells. Blood J Am Soc Hematol. 2002;99:1373\u201380.","journal-title":"Blood J Am Soc Hematol"},{"key":"1112_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1034\/j.1600-0609.2002.02785.x","volume":"69","author":"MJ Veuger","year":"2002","unstructured":"Veuger MJ, Honders MW, Willemze R, Barge RM. Deoxycytidine kinase expression and activity in patients with resistant versus sensitive acute myeloid leukemia. Eur J Haematol. 2002;69:171\u20138.","journal-title":"Eur J Haematol"},{"key":"1112_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-017-01834-4","volume":"8","author":"A Di Tullio","year":"2017","unstructured":"Di Tullio A, Rouault-Pierre K, Abarrategi A, Mian S, Grey W, Gribben J, et al. The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemia. Nat Commun. 2017;8:1\u201312.","journal-title":"Nat Commun"},{"key":"1112_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4161\/cc.4.1.1299","volume":"4","author":"SH Cho","year":"2005","unstructured":"Cho SH, Toouli CD, Fujii GH, Crain C, Parry D. Chk1 is essential for tumor cell viability following activation of the replication checkpoint. Cell Cycle. 2005;4:131\u20139.","journal-title":"Cell Cycle"},{"key":"1112_CR16","doi-asserted-by":"publisher","first-page":"18641","DOI":"10.1074\/jbc.M313536200","volume":"279","author":"D Loegering","year":"2004","unstructured":"Loegering D, Arlander SJ, Hackbarth J, Vroman BT, Roos-Mattjus P, Hopkins KM, et al. Rad9 protects cells from topoisomerase poison-induced cell death. J Biol Chem. 2004;279:18641\u20137.","journal-title":"J Biol Chem"},{"key":"1112_CR17","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1182\/blood-2004-09-3523","volume":"106","author":"RA Mesa","year":"2005","unstructured":"Mesa RA, Loegering D, Powell HL, Flatten K, Arlander SJ, Dai NT, et al. Heat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabine. Blood. 2005;106:318\u201327.","journal-title":"Blood"},{"key":"1112_CR18","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1128\/MCB.21.13.4129-4139.2001","volume":"21","author":"H Zhao","year":"2001","unstructured":"Zhao H, Piwnica-Worms H. ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol Cell Biol. 2001;21:4129\u201339.","journal-title":"Mol Cell Biol"},{"key":"1112_CR19","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1158\/2159-8290.CD-21-0410","volume":"12","author":"D Malani","year":"2022","unstructured":"Malani D, Kumar A, Br\u00fcck O, Kontro M, Yadav B, Helles\u00f8y M, et al. Implementing a functional precision medicine tumor board for acute myeloid leukemia. Cancer Discov. 2022;12:388\u2013401.","journal-title":"Cancer Discov"},{"key":"1112_CR20","doi-asserted-by":"crossref","unstructured":"Lenain C, Gusyatiner O, Douma S, van den Broek B, Peeper DS. Autophagy-mediated degradation of nuclear envelope proteins during oncogene-induced senescence. Carcinogenesis. 2015;36:1263\u201374.","DOI":"10.1093\/carcin\/bgv124"},{"key":"1112_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/8815349","volume":"2020","author":"X Zhao","year":"2020","unstructured":"Zhao X, Liu L, Jiang Y, Silva M, Zhen X, Zheng W. Protective effect of metformin against hydrogen peroxide-induced oxidative damage in human retinal pigment epithelial (RPE) cells by enhancing autophagy through activation of AMPK pathway. Oxid Med Cell Longev. 2020;2020:1\u201314.","journal-title":"Oxid Med Cell Longev"},{"key":"1112_CR22","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51:D638\u2013D646.","journal-title":"Nucleic Acids Res"},{"key":"1112_CR23","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/bioinformatics\/btq675","volume":"27","author":"ME Smoot","year":"2011","unstructured":"Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics. 2011;27:431\u20132.","journal-title":"Bioinformatics"},{"key":"1112_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY. CytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8:1\u20137.","journal-title":"BMC Syst Biol"},{"key":"1112_CR25","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","volume":"569","author":"M Ghandi","year":"2019","unstructured":"Ghandi M, Huang FW, Jan\u00e9-Valbuena J, Kryukov GV, Lo CC, McDonald ER, et al. Next-generation characterization of the cancer cell line encyclopedia. Nature. 2019;569:503\u20138.","journal-title":"Nature"},{"key":"1112_CR26","doi-asserted-by":"publisher","first-page":"D955","DOI":"10.1093\/nar\/gks1111","volume":"41","author":"W Yang","year":"2012","unstructured":"Yang W, Soares J, Greninger P, Edelman EJ, Lightfoot H, Forbes S, et al. Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2012;41:D955\u2013D961.","journal-title":"Nucleic Acids Res"},{"key":"1112_CR27","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2018.03.052","volume":"173","author":"AC Bester","year":"2018","unstructured":"Bester AC, Lee JD, Chavez A, Lee YR, Nachmani D, Vora S, et al. An integrated genome-wide CRISPRa approach to functionalize lncRNAs in drug resistance. Cell. 2018;173:649\u201364.e20.","journal-title":"Cell"},{"key":"1112_CR28","doi-asserted-by":"publisher","first-page":"11886","DOI":"10.18632\/oncotarget.2620","volume":"5","author":"Y Yang","year":"2014","unstructured":"Yang Y, Su D, Zhao L, Zhang D, Xu J, Wan J, et al. Different effects of LDH-A inhibition by oxamate in non-small cell lung cancer cells. Oncotarget. 2014;5:11886\u201396.","journal-title":"Oncotarget"},{"key":"1112_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.canlet.2014.11.046","volume":"358","author":"Z Zhao","year":"2015","unstructured":"Zhao Z, Han F, Yang S, Wu J, Zhan W. Oxamate-mediated inhibition of lactate dehydrogenase induces protective autophagy in gastric cancer cells: involvement of the Akt\u2013mTOR signaling pathway. Cancer Lett. 2015;358:17\u201326.","journal-title":"Cancer Lett"},{"key":"1112_CR30","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.ccr.2012.02.019","volume":"21","author":"O Mikhaylova","year":"2012","unstructured":"Mikhaylova O, Stratton Y, Hall D, Kellner E, Ehmer B, Drew AF, et al. VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma. Cancer Cell. 2012;21:532\u201346.","journal-title":"Cancer Cell"},{"key":"1112_CR31","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1038\/emboj.2010.74","volume":"29","author":"H Weidberg","year":"2010","unstructured":"Weidberg H, Shvets E, Shpilka T, Shimron F, Shinder V, Elazar Z. LC3 and GATE\u201016\/GABARAP subfamilies are both essential yet act differently in autophagosome biogenesis. EMBO J. 2010;29:1792\u2013802.","journal-title":"EMBO J"},{"key":"1112_CR32","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1083\/jcb.152.4.657","volume":"152","author":"N Mizushima","year":"2001","unstructured":"Mizushima N, Yamamoto A, Hatano M, Kobayashi Y, Kabeya Y, Suzuki K, et al. Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. J Cell Biol. 2001;152:657\u201368.","journal-title":"J Cell Biol"},{"key":"1112_CR33","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006;313:1929\u201335.","journal-title":"Science"},{"key":"1112_CR34","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","volume":"171","author":"A Subramanian","year":"2017","unstructured":"Subramanian A, Narayan R, Corsello SM, Peck DD, Natoli TE, Lu X, et al. A next generation connectivity map: L1000 platform and the first 1,000,000 profiles. Cell. 2017;171:1437\u201352.e17.","journal-title":"Cell"},{"key":"1112_CR35","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1172\/JCI73941","volume":"125","author":"E White","year":"2015","unstructured":"White E. The role for autophagy in cancer. J Clin Invest. 2015;125:42\u20136.","journal-title":"J Clin Invest"},{"key":"1112_CR36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ccr.2006.06.001","volume":"10","author":"K Degenhardt","year":"2006","unstructured":"Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G, et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell. 2006;10:51\u201364.","journal-title":"Cancer Cell"},{"key":"1112_CR37","first-page":"2349","volume":"125","author":"EY Liu","year":"2012","unstructured":"Liu EY, Ryan KM. Autophagy and cancer\u2013issues we need to digest. J Cell Sci. 2012;125:2349\u201358.","journal-title":"J Cell Sci"},{"key":"1112_CR38","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1126\/science.1193497","volume":"330","author":"JD Rabinowitz","year":"2010","unstructured":"Rabinowitz JD, White E. Autophagy and metabolism. Science. 2010;330:1344\u20138.","journal-title":"Science"},{"key":"1112_CR39","doi-asserted-by":"publisher","first-page":"5308","DOI":"10.1158\/1078-0432.CCR-07-5023","volume":"15","author":"E White","year":"2009","unstructured":"White E, DiPaola RS. The double-edged sword of autophagy modulation in cancer autophagy in cancer therapy. Clin Cancer Res. 2009;15:5308\u201316.","journal-title":"Clin Cancer Res"},{"key":"1112_CR40","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2174\/1574884708666131111204440","volume":"10","author":"S Goel","year":"2015","unstructured":"Goel S, Huang J, Klampfer L. K-Ras, intestinal homeostasis and colon cancer. Curr Clin Pharmacol. 2015;10:73\u201381.","journal-title":"Curr Clin Pharmacol"},{"key":"1112_CR41","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1101\/gad.2016311","volume":"25","author":"JY Guo","year":"2011","unstructured":"Guo JY, Chen HY, Mathew R, Fan J, Strohecker AM, Karsli-Uzunbas G, et al. Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev. 2011;25:460\u201370.","journal-title":"Genes Dev"},{"key":"1112_CR42","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrm2438","volume":"9","author":"AE Karnoub","year":"2008","unstructured":"Karnoub AE, Weinberg RA. Ras oncogenes: split personalities. Nat Rev Mol Cell Biol. 2008;9:517\u201331.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1112_CR43","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/pros.23709","volume":"79","author":"Z Chen","year":"2019","unstructured":"Chen Z, Jiang Q, Zhu P, Chen Y, Xie X, Du Z, et al. NPRL2 enhances autophagy and the resistance to Everolimus in castration\u2010resistant prostate cancer. Prostate. 2019;79:44\u201353.","journal-title":"Prostate"},{"key":"1112_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-018-0880-6","volume":"37","author":"X Xiao","year":"2018","unstructured":"Xiao X, Wang W, Li Y, Yang D, Li X, Shen C, et al. HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma. J Exp Clin Cancer Res. 2018;37:1\u201313.","journal-title":"J Exp Clin Cancer Res"},{"key":"1112_CR45","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3892\/mmr.2014.2671","volume":"11","author":"L Bao","year":"2015","unstructured":"Bao L, Jaramillo MC, Zhang Z, Zheng Y, Yao M, Zhang DD, et al. Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells. Mol Med Rep. 2015;11:91\u20138.","journal-title":"Mol Med Rep"},{"key":"1112_CR46","doi-asserted-by":"publisher","first-page":"17163","DOI":"10.1074\/jbc.M114.558288","volume":"289","author":"J Wang","year":"2014","unstructured":"Wang J, Wu GS. Role of autophagy in cisplatin resistance in ovarian cancer cells. J Biol Chem. 2014;289:17163\u201373.","journal-title":"J Biol Chem"},{"key":"1112_CR47","first-page":"645","volume":"31","author":"C Cheng","year":"2017","unstructured":"Cheng C, Liu J, Wang J, Li Y, Pan J, Zhang Y. Autophagy inhibition increased the anti-tumor effect of cisplatin on drug-resistant esophageal cancer cells. J Biol Regul Homeost Agents. 2017;31:645\u201352.","journal-title":"J Biol Regul Homeost Agents"},{"key":"1112_CR48","doi-asserted-by":"publisher","first-page":"e2540","DOI":"10.1038\/cddis.2016.461","volume":"8","author":"F Jin","year":"2018","unstructured":"Jin F, Wang Y, Li M, Zhu Y, Liang H, Wang C, et al. MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy. Cell Death Dis. 2018;8:e2540.","journal-title":"Cell Death Dis"},{"key":"1112_CR49","first-page":"189","volume":"15","author":"HB Frieboes","year":"2014","unstructured":"Frieboes HB, Huang JS, Yin WC, McNally LR. Chloroquine-mediated cell death in metastatic pancreatic adenocarcinoma through inhibition of autophagy. JOP. 2014;15:189\u201397.","journal-title":"JOP"},{"key":"1112_CR50","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.kjms.2017.01.004","volume":"33","author":"YC Lin","year":"2017","unstructured":"Lin YC, Lin JF, Wen SI, Yang SC, Tsai TF, Chen HE, et al. Chloroquine and hydroxychloroquine inhibit bladder cancer cell growth by targeting basal autophagy and enhancing apoptosis. Kaohsiung J Med Sci. 2017;33:215\u201323.","journal-title":"Kaohsiung J Med Sci"},{"key":"1112_CR51","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.biocel.2019.01.020","volume":"111","author":"ZC Wang","year":"2019","unstructured":"Wang ZC, Huang FZ, Xu HB, Sun JC, Wang CF. MicroRNA-137 inhibits autophagy and chemosensitizes pancreatic cancer cells by targeting ATG5. Int J Biochem Cell Biol. 2019;111:63\u201371.","journal-title":"Int J Biochem Cell Biol"},{"key":"1112_CR52","first-page":"6859","volume":"17","author":"J Chen","year":"2018","unstructured":"Chen J, Zhang L, Zhou H, Wang W, Luo Y, Yang H, et al. Inhibition of autophagy promotes cisplatin-induced apoptotic cell death through Atg5 and Beclin 1 in A549 human lung cancer cells. Mol Med Rep. 2018;17:6859\u201365.","journal-title":"Mol Med Rep"},{"key":"1112_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-019-0921-z","volume":"19","author":"J Tang","year":"2019","unstructured":"Tang J, Zhu J, Ye Y, Liu Y, He Y, Zhang L, et al. Inhibition LC3B can increase chemosensitivity of ovarian cancer cells. Cancer Cell Int. 2019;19:1\u201315.","journal-title":"Cancer Cell Int"},{"key":"1112_CR54","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.4161\/15548627.2014.981788","volume":"10","author":"S Lefort","year":"2014","unstructured":"Lefort S, Joffre C, Kieffer Y, Givel AM, Bourachot B, Zago G, et al. Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancers. Autophagy. 2014;10:2122\u201342.","journal-title":"Autophagy"},{"key":"1112_CR55","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/448645a","volume":"448","author":"CR Chong","year":"2007","unstructured":"Chong CR, Sullivan DJ. New uses for old drugs. Nature. 2007;448:645\u20136.","journal-title":"Nature"},{"key":"1112_CR56","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.3390\/jcm9061892","volume":"9","author":"D Valli","year":"2020","unstructured":"Valli D, Gruszka AM, Alcalay M. Has drug repurposing fulfilled its promise in acute myeloid leukaemia? J Clin Med. 2020;9:1892.","journal-title":"J Clin Med"},{"key":"1112_CR57","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1158\/1078-0432.CCR-10-2634","volume":"17","author":"RK Amaravadi","year":"2011","unstructured":"Amaravadi RK, Lippincott-Schwartz J, Yin XM, Weiss WA, Takebe N, Timmer W, et al. Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res. 2011;17:654\u201366.","journal-title":"Clin Cancer Res"},{"key":"1112_CR58","doi-asserted-by":"publisher","first-page":"337","DOI":"10.7326\/0003-4819-144-5-200603070-00008","volume":"144","author":"J Sotelo","year":"2006","unstructured":"Sotelo J, Brice\u00f1o E, L\u00f3pez-Gonz\u00e1lez MA. Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2006;144:337\u201343.","journal-title":"Ann Intern Med"},{"key":"1112_CR59","doi-asserted-by":"publisher","first-page":"e29911","DOI":"10.4161\/mco.29911","volume":"1","author":"G Manic","year":"2014","unstructured":"Manic G, Obrist F, Kroemer G, Vitale I, Galluzzi L. Chloroquine and hydroxychloroquine for cancer therapy. Mol Cell Oncol. 2014;1:e29911.","journal-title":"Mol Cell Oncol"},{"key":"1112_CR60","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1517\/13543776.2015.1050791","volume":"25","author":"PM Njaria","year":"2015","unstructured":"Njaria PM, Okombo J, Njuguna NM, Chibale K. Chloroquine-containing compounds: a patent review (2010\u20132014). Expert Opin Ther Pat. 2015;25:1003\u201324.","journal-title":"Expert Opin Ther Pat"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-023-01112-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-023-01112-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-023-01112-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T09:03:53Z","timestamp":1698743033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-023-01112-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,14]]},"references-count":60,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["1112"],"URL":"https:\/\/doi.org\/10.1038\/s41401-023-01112-8","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,14]]},"assertion":[{"value":"19 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}